Resmetirom Interactions
There are 135 drugs known to interact with resmetirom, along with 1 disease interaction. Of the total drug interactions, 19 are major, and 116 are moderate.
- View resmetirom disease interactions (1)
Medications known to interact with resmetirom
Note: Showing generic names only.
A
- abiraterone
- afatinib
- alpelisib
- amprenavir
- artesunate
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atazanavir
- atogepant
- atorvastatin
B
C
- calaspargase pegol
- cannabidiol
- cerivastatin
- cladribine
- clofarabine
- clopidogrel
- cobicistat
- cyclosporine
D
- daclatasvir
- daclizumab
- darolutamide
- darunavir
- daunorubicin
- deferasirox
- delafloxacin
- disulfiram
- doxorubicin
- doxorubicin liposomal
E
- efavirenz
- eltrombopag
- eluxadoline
- empagliflozin
- enasidenib
- encorafenib
- entrectinib
- enzalutamide
- epirubicin
- ezetimibe
F
G
I
- idelalisib
- imatinib
- indinavir
- interferon beta-1a
- interferon beta-1b
- irinotecan
- isoniazid
- isotretinoin
K
L
- lapatinib
- larotrectinib
- leflunomide
- leniolisib
- letermovir
- levoketoconazole
- lomitapide
- lovastatin
- lurasidone
- lusutrombopag
M
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pexidartinib
- pioglitazone
- pirtobrutinib
- pitavastatin
- pralsetinib
- pravastatin
R
- remdesivir
- repaglinide
- revefenacin
- rifampin
- rifaximin
- riociguat
- ripretinib
- ritonavir
- rivaroxaban
- rosiglitazone
- rosuvastatin
- rucaparib
S
T
- talazoparib
- telaprevir
- telithromycin
- teriflunomide
- thioguanine
- tipranavir
- topotecan
- trabectedin
- treprostinil
- tretinoin
- trofinetide
- tucatinib
U
V
Z
Resmetirom disease interactions
There is 1 disease interaction with resmetirom which include:
More about resmetirom
- resmetirom consumer information
- Compare alternatives
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.